Filing Details

Accession Number:
0000899243-21-035755
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-14 07:10:28
Reporting Period:
2021-09-09
Accepted Time:
2021-09-14 07:10:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1809519 Goodrx Holdings Inc. GDRX Services-Computer Processing & Data Preparation (7374) 475104396
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1822193 Babak Azad C/O Goodrx Holdings, Inc.
2701 Olympic Boulevard
Santa Monica CA 90404
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-09-09 12,500 $5.94 12,500 No 4 M Direct
Class A Common Stock Disposition 2021-09-09 1,801 $40.42 10,699 No 4 S Direct
Class A Common Stock Disposition 2021-09-09 3,400 $41.42 7,299 No 4 S Direct
Class A Common Stock Disposition 2021-09-09 7,299 $42.53 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Option (Right to Buy) Disposition 2021-09-09 12,500 $0.00 12,500 $5.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
312,500 2030-01-30 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of December 9, 2020.
  2. This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.01 to $40.96. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.05 to $41.92. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.05 to $42.94. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on October 9, 2019.